The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Management of Graves Disease: A Review
Abstract
IMPORTANCE: Graves disease is the most common cause of persistent hyperthyroidism in adults. Approximately 3% of women and 0.5% of men will develop Graves disease during their lifetime. OBSERVATIONS: We searched PubMed and the Cochrane database for English-language studies published from June 2000 through October 5, 2015. Thirteen randomized clinical trials, 5 systematic reviews and meta-analyses, and 52 observational studies were included in this review. Patients with Graves disease may be treated with antithyroid drugs, radioactive iodine (RAI), or surgery (near-total thyroidectomy). The optimal approach depends on patient preference, geography, and clinical factors. A 12- to 18-month course of antithyroid drugs may lead to a remission in approximately 50% of patients but can cause potentially significant (albeit rare) adverse reactions, including agranulocytosis and hepatotoxicity. Adverse reactions typically occur within the first 90 days of therapy. Treating Graves disease with RAI and surgery result in gland destruction or removal, necessitating life-long levothyroxine replacement. Use of RAI has also been associated with the development or worsening of thyroid eye disease in approximately 15% to 20% of patients. Surgery is favored in patients with concomitant suspicious or malignant thyroid nodules, coexisting hyperparathyroidism, and in patients with large goiters or moderate to severe thyroid eye disease who cannot be treated using antithyroid drugs. However, surgery is associated with potential complications such as hypoparathyroidism and vocal cord paralysis in a small proportion of patients. In pregnancy, antithyroid drugs are the primary therapy, but some women with Graves disease opt to receive definitive therapy with RAI or surgery prior to becoming pregnant to avoid potential teratogenic effects of antithyroid drugs during pregnancy. CONCLUSIONS AND RELEVANCE: Management of Graves disease includes treatment with antithyroid drugs, RAI, or thyroidectomy. The optimal approach depends on patient preference and specific patient clinical features such as age, history of arrhythmia or ischemic heart disease, size of goiter, and severity of thyrotoxicosis. Physicians should be familiar with the advantages and disadvantages of each therapy to best counsel their patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
De Groot, L., Abalovich, M., Alexander, E. K., Amino, N., Barbour, L., Cobin, R. H., Eastman, C. J., Lazarus, J. H., Luton, D., Mandel, S. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2803 · Cited by 1,866
The Transfer of Drugs and Other Chemicals Into Human Milk
Committee on Drugs (2001) · Pediatrics · doi:10.1542/peds.108.3.776 · Cited by 1,256
Thyroid Function and Human Reproductive Health
Krassas, G. E., Poppe, K., & Glinoer, D. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0041 · Cited by 1,223
The Importance of Surgeon Experience for Clinical and Economic Outcomes From Thyroidectomy
Sosa, J. A., Bowman, H. M., Tielsch, J. M., Powe, N. R., Gordon, T. A., & Udelsman, R. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00005 · Cited by 1,118
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Life-Threatening Thyrotoxicosis: Thyroid Storm
Burch, H. B., & Wartofsky, L. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30165-8 · Cited by 852
Self-citationNavarro, V. J., & Senior, J. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052270 · Cited by 811
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
Thyroid Diseases after Treatment of Hodgkin's Disease
Hancock, S. L., Cox, R. S., & McDougall, I. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108293250902 · Cited by 579
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Smoking and Risk of Graves' Disease
Prummel, M. F. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500040045034 · Cited by 503
Transfer of drugs and other chemicals into human milk
Roberts, R., Blumer, J. L., Gorman, R. L., Lambert, G. H., Rumack, B. H., SNODGRASS, W. T., Bennett, D. R., ', J. C., Petricciani, J. C., Licata, S., et al. (1989) · PEDIATRICS · Cited by 503
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
Andersohn, F., Konzen, C., & Garbe, E. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00009 · Cited by 479
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
Cancer Mortality Following Treatment for Adult Hyperthyroidism
Ron, E. (1998) · JAMA · doi:10.1001/jama.280.4.347 · Cited by 377
A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease
Burch, H. B., Burman, K. D., & Cooper, D. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2802 · Cited by 345
Self-citationSahu, M. T., Das, V., Mittal, S., Agarwal, A., & Sahu, M. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1105-1 · Cited by 336
Hyperthyroidism and risk of atrial fibrillation or flutter: A population-based study
Frost, L., Vestergaard, P. M., & Mosekilde, L. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.10.013 · Cited by 313
Cooper, D. S., & Laurberg, P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70086-x · Cited by 310
Self-citationVITTI, P., RAGO, T., CHIOVATO, L., PALLINI, S., SANTINI, F., FIORE, E., ROCCHI, R., MARTINO, E., & PINCHERA, A. (1997) · Thyroid · doi:10.1089/thy.1997.7.369 · Cited by 293
Radioiodine Therapy for Hyperthyroidism
Ross, D. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1007101 · Cited by 284
Extrathyroidal manifestations of Graves’ disease: a 2014 update
Bartalena, L., & Fatourechi, V. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0097-2 · Cited by 279
Nakamura, H., Noh, J. Y., Itoh, K., Fukata, S., Miyauchi, A., Hamada, N., & Working Group of the Japan Thyroid Association for the Guideline of the Treatment of Graves’ Disease (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2135 · Cited by 277
Birth Defects After Early Pregnancy Use of Antithyroid Drugs: A Danish Nationwide Study
Andersen, S. L., Olsen, J., Wu, C. S., & Laurberg, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2831 · Cited by 267
Träisk, F., Tallstedt, L., Abraham-Nordling, M., Andersson, T., Berg, G., Calissendorff, J., Hallengren, B., Hedner, P., Lantz, M., Nyström, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0747 · Cited by 262
High Dose 131I Therapy for the Treatment of Hyperthyroidism Caused by Graves' Disease
Alexander, E. K. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1073 · Cited by 251
Sundaresh, V., Brito, J. P., Wang, Z., Prokop, L. J., Stan, M. N., Murad, M. H., & Bahn, R. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1954 · Cited by 250
Sisson, T. A. T. A. T., Freitas, J., McDougall, I. R., Dauer, L. T., Hurley, J. R., Brierley, J. D., Edinboro, C. H., Rosenthal, D., Thomas, M. J., Wexler, J. A., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0403 · Cited by 234
Yoshihara, A., Noh, J., Yamaguchi, T., Ohye, H., Sato, S., Sekiya, K., Kosuga, Y., Suzuki, M., Matsumoto, M., Kunii, Y., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2860 · Cited by 231
Bahn, R. S., Burch, H. S., Cooper, D. S., Garber, J. R., Greenlee, C. M., Klein, I. L., Laurberg, P., McDougall, I. R., Rivkees, S. A., Ross, D., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0169 · Cited by 223
Self-citationAggravation of Thyrotoxicosis in Early Pregnancy and after Delivery in Graves' Disease*
AMINO, N., TANIZAWA, O., MORI, H., IWATANI, Y., YAMADA, T., KURACHI, K., KUMAHARA, Y., & MIYAI, K. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-1-108 · Cited by 211
Walter, M. A., Briel, M., Christ-Crain, M., Bonnema, S. J., Connell, J., Cooper, D. S., Bucher, H. C., Müller-Brand, J., & Müller, B. (2007) · BMJ · doi:10.1136/bmj.39114.670150.be · Cited by 202
Self-citationAcharya, S. H., Avenell, A., Philip, S., Burr, J., Bevan, J. S., & Abraham, P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03279.x · Cited by 200
Stagnaro‐Green, A., Abalovich, M., Alexander, E. K., Azizi, F., Mestman, J. H., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., & Wiersinga, W. M. (2011) · Cited by 199
Boelaert, K., Torlinska, B., Holder, R. L., & Franklyn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2495 · Cited by 196
Analysis of 754 Cases of Antithyroid Drug-Induced Agranulocytosis Over 30 Years in Japan
Nakamura, H., Miyauchi, A., Miyawaki, N., & Imagawa, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2569 · Cited by 180
Dermopathy of Graves' Disease (Pretibial Myxedema): Long-Term Outcome
Schwartz, K. M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.438 · Cited by 176
β-Adrenergic blockade for the treatment of hyperthyroidism
Geffner, D. L., & Hershman, J. M. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90681-z · Cited by 168
Abraham-Nordling, M., Törring, O., Hamberger, B., Lundell, G., Tallstedt, L., Calissendorff, J., & Wallin, G. (2005) · Thyroid · doi:10.1089/thy.2005.15.1279 · Cited by 163
Radioiodine-induced thyroid storm
McDermott, M. T., Kidd, G. S., Dodson, L. E., & Hofeldt, F. D. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91217-2 · Cited by 163
Erbil, Y., Ozluk, Y., Giriş, M., Salmaslıoglu, A., Issever, H., Barbaros, U., Kapran, Y., Özarmağan, S., & Tezelman, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0229 · Cited by 157
Tajiri, J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390150107020 · Cited by 156
Cooper, D. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030185 · Cited by 155
Self-citationNyström, H. F., Jansson, S. K. G., & Berg, G. E. B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12060 · Cited by 153
Quality of life in Graves’ ophthalmopathy
Wiersinga, W. M. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.11.001 · Cited by 148
Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine
Azizi, F., Ataie, L., Hedayati, M., Mehrabi, Y., & Sheikholeslami, F. H. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01904 · Cited by 146
Remission of Graves’ disease during anti-thyroid drug therapy. Time to reconsider the mechanism?
Laurberg, P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02295 · Cited by 139
Thyrotoxicosis and heart failure that complicate pregnancy
Sheffield, J. S., & Cunningham, F. G. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00944-x · Cited by 137
Review article: Drug‐induced anti‐neutrophil cytoplasmic antibody‐associated vasculitis
Gao, Y., & Zhao, M. (2009) · Nephrology · doi:10.1111/j.1440-1797.2009.01100.x · Cited by 136
Weight gain following treatment of hyperthyroidism
Dale, J., Daykin, J., Holder, R. L., Sheppard, M. C., & Franklyn, J. A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01329.x · Cited by 136
Graves Hyperthyroidism and Pregnancy: A Clinical Update
Patil-Sisodia, K., & Mestman, J. H. (2009) · Endocrine Practice · doi:10.4158/ep09233.ra · Cited by 134
Perioperative management of the thyrotoxic patient
Langley, R. W., & Burch, H. B. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00010-0 · Cited by 131
Self-citationVariation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel.
McLeod, D. S. A., Caturegli, P., Cooper, D. S., Matos, P. G., & Hutfless, S. (2014) · JAMA · doi:10.1001/jama.2013.285606 · Cited by 128
Self-citationTakata, K., Kubota, S., Fukata, S., Kudo, T., Nishihara, E., Ito, M., Amino, N., & Miyauchi, A. (2009) · Thyroid · doi:10.1089/thy.2008.0364 · Cited by 128
Methimazole-Induced Hepatotoxicity
Woeber, K. A. (2002) · Endocrine Practice · doi:10.4158/ep.8.3.222 · Cited by 126
Outcomes of pregnancy complicated with hyperthyroidism: a cohort study
Luewan, S., Chakkabut, P., & Tongsong, T. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1362-z · Cited by 123
Carella, C., Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Nersita, R., Iorio, S., Amato, G., Braverman, L. E., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.295 · Cited by 119
Antithyroid drug‐related hepatotoxicity in hyperthyroidism patients: a population‐based cohort study
Wang, M., Lee, W., Huang, T., Chu, C., & Hsieh, C. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12336 · Cited by 114
Emiliano, A. B., Governale, L. A., Parks, M. A., & Cooper, D. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2752 · Cited by 112
Self-citationBraverman, L. E., & Utiger, R. D. (2020) · Cited by 112
Thyroid Function and Intellectual Development of Infants Nursed by Mothers Taking Methimazole
Azizi, F., Khoshniat, M., Bahrainian, M., & Hedayati, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6810 · Cited by 110
Santos, A. M., Nobre, E. L., Costa, J. G. E., Nogueira, P., Macedo, A., Galvão-Teles, A., & Castro, J. J. D. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01332.x · Cited by 110
Burch, H. B., Solomon, B. L., Cooper, D. S., Ferguson, P., Walpert, N., & Howard, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7639 · Cited by 110
Self-citationRotondi, M., Cappelli, C., Pirali, B., Pirola, I., Magri, F., Fonte, R., Castellano, M., Rosei, E. A., & Chiovato, L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0966 · Cited by 109
Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy
Kriplani, A., Buckshee, K., Bhargava, V. L., Takkar, D., & Ammini, A. C. (1994) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(94)90276-3 · Cited by 104
Braga, M., Walpert, N., Burch, H. B., Solomon, B. L., & Cooper, D. S. (2002) · Thyroid · doi:10.1089/105072502753522365 · Cited by 104
Self-citationClinical presentation and management of drug-induced agranulocytosis
Andrès, E., Zimmer, J., Mecili, M., Weitten, T., Alt, M., & Maloisel, F. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.12 · Cited by 96
Diagnosis and Management of Graves' Disease in Pregnancy
Hamburger, J. I. (1992) · Thyroid · doi:10.1089/thy.1992.2.219 · Cited by 94
Korelitz, J. J., McNally, D. L., Masters, M. N., Li, S. X., Xu, Y., & Rivkees, S. A. (2013) · Thyroid® · doi:10.1089/thy.2012.0488 · Cited by 91
Harper, L., Chin, L. S., Daykin, J., Allahabadia, A., Heward, J. M., Gough, S. C. L., Savage, C. O. S., & Franklyn, J. A. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02029.x · Cited by 88
The American Thyroid Association
(1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-8-1021a · Cited by 86
Goitre size and outcome of medical treatment of Graves' disease
Laurberg, P., Buchholtz, P. E., Iversen, E., Jensen, S. E., & Weeke, J. (1986) · European Journal of Endocrinology · doi:10.1530/acta.0.1110039 · Cited by 86
Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections
Sheng, W. (1999) · QJM · doi:10.1093/qjmed/92.8.455 · Cited by 83
Shiber, S., Stiebel‐Kalish, H., Shimon, I., Grossman, A., & Robenshtok, E. (2014) · Thyroid · doi:10.1089/thy.2014.0218 · Cited by 82
Treatment Options for Graves Disease: A Cost-Effectiveness Analysis
In, H., Pearce, E. N., Wong, A. K. G., Burgess, J. F., McAneny, D. B., & Rosen, J. E. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.03.025 · Cited by 81
Bone mineral density in hyperthyroidism
Karga, H., Papapetrou, P. D., Korakovouni, A., Papandroulaki, F., Polymeris, A., & Pampouras, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02110.x · Cited by 75
Feroci, F., Rettori, M., Borrelli, A., Coppola, A., Castagnoli, A., Perigli, G., Cianchi, F., & Scatizzi, M. (2013) · Surgery · doi:10.1016/j.surg.2013.10.017 · Cited by 70
Okamura, K., Sato, K., Fujikawa, M., Bandai, S., Ikenoue, H., & Kitazono, T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4466 · Cited by 64
Gao, Y., Chen, M., Ye, H., Yu, F., Guo, X.-H., & Zhao, M.-H. (2008) · Rheumatology · doi:10.1093/rheumatology/ken321 · Cited by 64
Hepatotoxicity and cutaneous reactions after antithyroid drug administration
Otsuka, F., Noh, J. Y., Chino, T., Shimizu, T., Mukasa, K., Ito, K., Ito, K., & Taniyama, M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04365.x · Cited by 63
Analysis of 90 Cases of Antithyroid Drug-Induced Severe Hepatotoxicity Over 13 Years in China
Yang, J., Li, L.-F., Xu, Q., Zhang, J., Weng, W.-W., Zhu, Y.-J., & Dong, M.-J. (2015) · Thyroid · doi:10.1089/thy.2014.0350 · Cited by 60
Perrild, H., Hansen, J., Skovsted, L., & Christensen, L. K. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb03196.x · Cited by 58
Prediction of Remission after Antithyroid Drug Treatment in Graves' Disease
Young, E. T., STEEL, N. R., Taylor, J. J., Stephenson, A. M., Stratton, A., Holcombe, M., & Kendall-Taylor, P. (1988) · QJM · doi:10.1093/oxfordjournals.qjmed.a068188 · Cited by 58
Ide, A., Amino, N., Kang, S., Yoshioka, W., Kudo, T., Nishihara, E., Ito, M., Nakamura, H., & Miyauchi, A. (2014) · Thyroid® · doi:10.1089/thy.2013.0585 · Cited by 56
The Cost Effectiveness of Treatment Modalities for Thyrotoxicosis in a U.K. Center
Patel, N., Abraham, P., Buscombe, J. R., & Vanderpump, M. P. J. (2006) · Thyroid · doi:10.1089/thy.2006.16.593 · Cited by 56
Discontinuing Antithyroid Drug Therapy before Ablation with Radioiodine in Graves Disease
Burch, H. B., Solomon, B. L., Wartofsky, L., & Burman, K. D. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-8-199410150-00001 · Cited by 55
Self-citationAutoimmunity and Graves’ Disease
Bahn, R. S. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.10 · Cited by 55
Hyperthyroxinemia in patients treated with high-dose propranolol
Cooper, D. S., Daniels, G. H., Ladenson, P. W., & Ridgway, E. C. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90778-1 · Cited by 54
Self-citationAndrade, V. A., Gross, J. L., & Maia, A. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6149 · Cited by 53
Walter, M. A., Christ-Crain, M., Schindler, C., Müller-Brand, J., & Müller, B. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0092-8 · Cited by 49
Uchida, T., Goto, H., Kasai, T., Komiya, K., Takeno, K., Abe, H., Shigihara, N., Sato, J., Honda, A., Mita, T., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0171-8 · Cited by 46
Kobayashi, S., Noh, J. Y., Mukasa, K., Kunii, Y., Watanabe, N., Matsumoto, M., Ohye, H., Suzuki, M., Yoshihara, A., Iwaku, K., et al. (2014) · Thyroid® · doi:10.1089/thy.2013.0476 · Cited by 45
Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves’ Disease
Elfenbein, D. M., Schneider, D. F., Havlena, J. A., Chen, H., & Sippel, R. S. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4095-6 · Cited by 45
Hepatotoxicity and cutaneous reactions after antithyroid drug administration
大塚, 史. (2012) · Medical Entomology and Zoology · Cited by 45
Roti, E. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380090021007 · Cited by 40
KASHIWAI, T., Hidaka, Y., Takano, T., Tatsumi, K.-I., Izumi, Y., Shimaoka, Y., Tada, H., Takeoka, K., & Amino, N. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.45 · Cited by 38
CHAN, J. J. S., & LADENSON, P. W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-1-102 · Cited by 35
Jin, J., Sandoval, V., Lawless, M. E., Sehgal, A. R., & McHenry, C. R. (2012) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2011.10.010 · Cited by 33
Liu, X., Qiang, W., Liu, X., Liu, L., Liu, S., Gao, A., Gao, S., & Shi, B. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0704 · Cited by 31
Kubota, S., Ohye, H., Genichiro, Y. A. N. O., Nishihara, E., Kudo, T., Ito, M., Fukata, S., Amino, N., Kuma, K., & Miyauchi, A. (2006) · Endocrine Journal · doi:10.1507/endocrj.k06-057 · Cited by 27
Patient Knowledge of Antithyroid Drug-Induced Agranulocytosis
Robinson, J., Richardson, M., Hickey, J., James, A., Pearce, S. H. S., Ball, S. G., Quinton, R., Morris, M., Miller, M. A., & Perros, P. (2014) · European Thyroid Journal · doi:10.1159/000367990 · Cited by 25
McCRUDEN, D. C., HILDITCH, T. E., CONNELL, J. M. C., McLELLAN, A. R., ROBERTSON, J., & ALEXANDER, W. D. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb03636.x · Cited by 21
Life-Threatening Thyrotoxicosis: Thyroid Storm and Adverse Effects of Antithyroid Drugs
Warnock, A., Cooper, D. S., & Burch, H. B. (2014) · The Endocrine Society eBooks · doi:10.1210/eme.9781936704811.ch11 · Cited by 6
Self-citation
Cited by
Smith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
The MHC locus and genetic susceptibility to autoimmune and infectious diseases
Matzaraki, V., Kumar, V., Wijmenga, C., & Zhernakova, A. (2017) · Genome biology · doi:10.1186/s13059-017-1207-1 · Cited by 566
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
The Impact of Obesity on Thyroid Autoimmunity and Dysfunction: A Systematic Review and Meta-Analysis
Song, R.-H., Wang, B., Yao, Q.-M., Li, Q., Jia, X., & Zhang, J.-A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02349 · Cited by 257
Metadata
- Authors
- Burch, H. B., & Cooper, D. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-12-15
- Volume
- 314
- Issue
- 23
- Pages
- 2544
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2205037416
- Cited by
- 332
- References
- 104
- FWCI
- 20.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.